aod9604 development discontinued 5mg | UK GH Fragment Research Peptide, ≥99% HPLC purity research formula manufactured in the USA AOD-9604 | Peptide Report
Description
Retatrutide layered glucagon receptor agonism on top and reached approximately 24% in Phase 2 data
Participants received pharmaceutical-grade product with verified purity
Alternate Sites: If rotating injection sites to prevent lipohypertrophy (tissue buildup), you may also use the outer thigh or upper arm fatty tissue
LC-MS/MS measurements confirmed both cofactors rose
